Results for kras translation from Danish to English

9 kras- mutationer
9 mutant kras

population med kras- vildtypen
kras wild-type population

teran | kras | kvbd | slovensk |
teran | kras | quality wine psr | slovenian |

muteret kras-population (exon 2)
mutant kras (exon 2) population

vildtype-kras-population (exon 2)
wild-type kras (exon 2) population

teran | kras | kvalitetsvin fso | slovenska |
teran | kras | quality wine psr | slovenian |

kras-mutationsstatus var tilgængelig for 2.072 patienter.
kras mutational status was available for 2072 patients.

kras er en af de hyppigst aktiverede oncogener ved human cancer.
kras is one of the most frequently activated oncogenes in human cancers.

reproduction is authorised provided the source is acknowledged. muteret kras.
reproduction is authorised provided the source is acknowledged.

kras er et gen, der stimulerer tumorvækst, når det muteres i tumorceller.
kras is a gene that, when mutated in tumour cells, stimulates tumour growth.

forskellen i pfs- median i gruppen med kras- mutationer var 0 uger.
the difference in median pfs in the kras mutant group was 0 weeks.

forskellen i pfs- median i gruppen med kras- vildtypen var 8 uger.
the difference in median pfs in the kras wild-type group was 8 weeks.

for 2% af patienterne med kras- vildtypen blev diaré indberettet som alvorlig.
two percent of patients with kras wild-type had diarrhoea reported as severe.

kras, også efterfulgt af navnet på et mindre geografisk område og/eller navnet på et vinbrug
kras whether or not followed by the name of a smaller geographic unit and/or the name of a vineyard estate

i gruppen med kras- vildtypen var responsraten 17% for panitumumab og 0% for bsc.
in the kras wild-type group the response rate was 17% for panitumumab and 0% for bsc.

ved metastatisk colorectal cancer ligger incidensen af kras- mutationer i området 30 - 50%.
in metastatic colorectal cancer, the incidence of kras mutations is in the range of 30 - 50%.

ved studiestart var kras-status vild (49%) eller muteret (51%).
kras status was wild (49%) or mutant (51%) at study entry.

forekomsten af disse yderligere ras-mutationer i populationen med vildtype-kras exon 2 var cirka 16 %.
the incidence of these additional ras mutations in the wild-type kras exon 2 population was approximately 16%.

427 (92%) patienter var evaluerbare for så vidt angår kras - status, og af disse havde 184 patienter mutationer.
427 (92%) patients were evaluable for kras status of which 184 had mutations.